6-Phosphogluconic acid
From WikiMD's Wellness Encyclopedia
6-Phosphogluconic acid (6PG) is a biochemical compound that plays a significant role in the pentose phosphate pathway (PPP), a metabolic pathway parallel to glycolysis. It is a phosphorylated derivative of gluconic acid, and its importance lies in its involvement in cellular processes such as nucleotide synthesis, redox regulation, and the production of NADPH, which is crucial for anabolic reactions and antioxidant defense mechanisms.
Structure and Properties[edit | edit source]
6-Phosphogluconic acid is a six-carbon carboxylic acid that contains a phosphate group attached to the sixth carbon atom. This structure is pivotal for its role in metabolism, as the phosphate group allows it to participate in enzymatic reactions that would not be possible for gluconic acid itself. The molecular formula of 6-phosphogluconic acid is C6H13O9P, and it exists in a linear form as well as a cyclic form under physiological conditions.
Metabolic Role[edit | edit source]
In the pentose phosphate pathway, 6-phosphogluconic acid is formed from glucose-6-phosphate through the action of the enzyme glucose-6-phosphate dehydrogenase (G6PD), which also produces NADPH in the process. This step is crucial for cells, especially in tissues that are highly active in lipid synthesis, such as the liver and adipose tissue, as well as in red blood cells where NADPH is essential for maintaining the reduced state of glutathione and protecting the cell from oxidative damage.
Following its formation, 6-phosphogluconic acid is further metabolized by the enzyme 6-phosphogluconate dehydrogenase, resulting in the production of ribulose 5-phosphate, another NADPH molecule, and carbon dioxide (CO2). Ribulose 5-phosphate can then enter the non-oxidative phase of the PPP, leading to the synthesis of ribose-5-phosphate, a precursor for nucleotide synthesis, or be isomerized to xylulose-5-phosphate and further processed to regenerate glucose-6-phosphate, thus linking the PPP with glycolysis and other metabolic pathways.
Clinical Significance[edit | edit source]
Alterations in the activity of enzymes involved in the metabolism of 6-phosphogluconic acid, particularly G6PD, can lead to metabolic disorders. G6PD deficiency, for example, is a genetic disorder that affects millions worldwide and can cause hemolytic anemia in response to certain medications, foods, or infections due to the reduced ability of red blood cells to counteract oxidative stress.
Research and Applications[edit | edit source]
Research into 6-phosphogluconic acid and its metabolic pathway has implications for understanding and treating various diseases, including cancer, where altered PPP activity has been observed. Targeting the enzymes of this pathway, such as 6-phosphogluconate dehydrogenase, is being explored as a potential therapeutic strategy.
See Also[edit | edit source]
References[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian